Company Filing History:
2 out of 2 
1 out of 832,812 Years Active: 2017-2021
Title: Victor Shifrin: Innovator in Inflammation and Cancer Treatment
Introduction
Victor Shifrin is a notable inventor based in Newton, MA (US). He has made significant contributions to the field of medical research, particularly in the treatment and prevention of inflammation-associated diseases and cancer. With a total of 3 patents, his work focuses on innovative methods and compositions that target critical health issues.
Latest Patents
Shifrin's latest patents include groundbreaking methods and compositions relating to p62/SQSTM1 for the treatment and prevention of inflammation-associated diseases. These novel p62 compositions are designed to modulate the expression of proinflammatory cytokines, osteogenic transcription factors, and bone resorptive factors. The applications of these compositions are extensive, addressing inflammatory diseases such as osteoporosis, obesity, type 2 diabetes, and various neurodegenerative diseases. Additionally, he has developed methods and compositions relating to p62 for the treatment and prophylaxis of cancer, enhancing the anti-cancer activity of p62 through modified compositions.
Career Highlights
Throughout his career, Victor Shifrin has worked with various organizations, including Curelab Oncology, Inc. His innovative research has positioned him as a key figure in the development of therapeutic strategies for complex diseases.
Collaborations
Shifrin has collaborated with notable professionals in his field, including Alexander Shneider and Franco Venanzi. These partnerships have contributed to the advancement of his research and the successful application of his inventions.
Conclusion
Victor Shifrin's contributions to medical research through his patents and collaborations highlight his commitment to addressing significant health challenges. His innovative approaches in treating inflammation and cancer continue to pave the way for future advancements in the field.